Exploration of the Social Cognition in Adolescents With a Dissociative Disorder or Autism Spectrum
EXPLORATION OF THE SOCIAL COGNITION IN ADOLESCENTS WITH A Dissociative Disorder OR AUTISM SPECTRUM
1 other identifier
interventional
60
1 country
3
Brief Summary
The schizophrenic disorders and pervasive developmental disorders are neurodevelopmental disorders distinct origin who share common challenges to engage and maintain social relationships and mutual disturbances of affective contact. An important issue of research is to determine the cognitive and brain mechanisms underlying social disability in these two pathologies. Several lines of social cognition have been systematically explored: the perception of emotions, the ability to attribute intentionality and mental states to others (theory of mind), the understanding of social situations in different contexts. We made the observation today that research findings clearly in the field of autism and schizophrenic disorders that converge on common patterns neurocognitive abnormalities. Consequently, many programs support published today use the same therapeutic targets and the same tools in both pathologies. This raises two questions of science: (1) whether the disorders of social cognition reported in the field of autism and schizophrenia are "specific deficit" and not "specific condition", that is to say they are inherent social disadvantage whatever condition or (2) if these disorders of social cognition is a pattern common to autism and schizophrenia but are the result of specific neurocognitive mechanisms and different in each these pathologies. Systematic exploration of these issues is a current issue for understanding the pathophysiological borders between the two neurodevelopmental disorders but also to better define the potential targets of therapeutic strategies, psycho-educational and remediation of disorders of social cognition in autism and schizophrenia. Main objective: To compare clinical cognitive profiles in adolescents with a schizophrenic disorder, autistic or healthy in the three areas of social cognition: perception of emotions, attribution of intentions to others (theory of mind) and style attribution. We shall constitute three population groups of patients, a group of patients meeting the diagnosis of schizophrenia, a group of patients with autism and a control group (healthy subjects).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable schizophrenia
Started Jan 2013
Shorter than P25 for not_applicable schizophrenia
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedFirst Submitted
Initial submission to the registry
February 22, 2013
CompletedFirst Posted
Study publicly available on registry
March 6, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2013
CompletedMarch 31, 2026
March 1, 2026
3 months
February 22, 2013
March 26, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Compare cognitive profiles in clinical adolescents with a schizophrenic disorder, autistic or healthy in the three areas of social cognition
Compare cognitive profiles in clinical adolescents with a schizophrenic disorder, autistic or healthy in the three areas of social cognition: the perception of emotions, attribution of intentions to others (theory of mind) and style attribution. We will study the brain evoked potentials during the execution of the task of facial emotion recognition.
First day
Secondary Outcomes (2)
Compare the cognitive profiles within the clinical group of schizophrenic
First day
Cognitive profiles compare clinical results between the different types of schizophrenia and autism patients.
First day
Study Arms (3)
schizophrenia
EXPERIMENTALchild with a DSM-IV diagnosis of schizophrenia
autism spectrum disorder
EXPERIMENTALchild with a DSM-IV diagnosis of autism spectrum disorder
Healthy
EXPERIMENTALchild having no DSM-IV diagnosis of schizophrenia spectrum disorder or autism
Interventions
The purpose is to consider the recognition of emotions expressed on face in patients with a schizophrenic disorder, autism and in healthy subjects.
Explore understanding of figurative language, including metaphor, in schizophrenic patients, autistic and healthy, and well understand how patients develop an interpretation from access to speaker's communicative intentionality (theory mind).
Compare the style of attribution of intentions in three populations of subjects: schizophrenic, autistic and healthy.
Eligibility Criteria
You may qualify if:
- Child with a DSM-IV diagnosis of schizophrenia or autism spectrum disorder:
- Schizophrenic patients, positive to the award of psychosis section of the Kiddie SADS and having a negative ADI.
- or:
- Patients with autism spectrum disorder, diagnosed by the scale ADI (Autism Diagnostic Interview) or ADOS (Autism Diagnostic Observation Schedule): Autism Asperger and PDD nos. These patients do not respond to a diagnosis of psychosis Kiddie-SADS according.
- Total IQ greater than or equal to 70
You may not qualify if:
- Genetic disorders, neurological and neurosensory
- Child satisfy both the diagnosis of autism spectrum disorder and schizophrenia than (comorbidity).
- Will not be included patients who participate in a study on rehabilitation for social skills.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Centre Hospitalier d'Antibes Juans les Pinscollaborator
- Centre Hospitalier de Cannescollaborator
- Centre Hospitalier Universitaire de Nicelead
Study Sites (3)
Centre Hospitalier d'Antibes Juans les Pins
Antibes, 06600, France
Centre hospitalier de Cannes
Cannes, 06400, France
CHU de Nice
Nice, 06000, France
Related Publications (1)
Bonnard-Couton V, Lubrano S, Tosello AL, Serret S, Askenazy-Gittard F. [Autism spectrum disorders, a pilot parent-child unit]. Soins Pediatr Pueric. 2018 Nov-Dec;39(305):37-41. doi: 10.1016/j.spp.2018.09.010. French.
PMID: 30449399RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Emmanuelle DOR, Medical Doctor
Centre Hospitalier Universitaire de Nice
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 22, 2013
First Posted
March 6, 2013
Study Start
January 1, 2013
Primary Completion
April 1, 2013
Study Completion
May 1, 2013
Last Updated
March 31, 2026
Record last verified: 2026-03